Should We Measure C-reactive Protein on Earth or Just on JUPITER?

被引：17

作者：

Bajpai, Ambareesh ^{[1
]}

Goyal, Abhinav ^{[1
]}

Sperling, Laurence ^{[1
]}

机构：

[1] Emory Univ, Dept Cardiol, Atlanta, GA 30322 USA

来源：

CLINICAL CARDIOLOGY | 2010年 / 33卷 / 04期

关键词：

CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK PREDICTION; MIDDLE-AGED MEN; FIBRIN D-DIMER; INFLAMMATORY MARKERS; RANDOMIZED-TRIAL; STATIN THERAPY; WOMEN; MORTALITY; INTERLEUKIN-6;

D O I：

10.1002/clc.20681

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Evidence for the role of inflammation in the pathogenesis of atherosclerosis is compelling and has generated interest in high-sensitivity C-reactive protein (hs-CRP) as a marker of cardiovascular risk. Data regarding hs-CRP and cardiovascular risk, though largely consistent, is of unclear clinical relevance. Most recently, the Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial has led to further debate regarding the utility of hs-CRP. This article provides a comprehensive review of the data regarding cardiovascular risk and hs-CRP with an emphasis on the JUPITER trial and concludes with an evidence-based analysis of the current role of hs-CRP in cardiovascular risk assessment.

引用

收藏

页码：190 / 198

页数：9

相关论文

共 49 条

[21] C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease - The Caerphilly and Speedwell studies [J].

Lowe, GDO ;

Sweetnam, PM ;

Yarnell, JWG ;

Rumley, A ;

Rumley, C ;

Bainton, D ;

Ben-Shlomo, Y .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (10) :1957-1962

[22] Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease [J].

Lowe, GDO ;

Rumley, A ;

McMahon, AD ;

Ford, I ;

O'Reilly, DS ;

Packard, CJ .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) :1529-1534

[23] C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease - The PRIME study [J].

Luc, G ;

Bard, JM ;

Juhan-Vague, I ;

Ferrieres, J ;

Evans, A ;

Amouyel, P ;

Arveiler, D ;

Fruchart, JC ;

Ducimetiere, P .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (07) :1255-1261

[24] Inflammatory markers and the risk of coronary heart disease in men and women. [J].

Pai, JK ;

Pischon, T ;

Ma, J ;

Manson, JE ;

Hankinson, SE ;

Joshipura, K ;

Curhan, GC ;

Rifai, N ;

Cannuscio, CC ;

Stampfer, MJ ;

Rimm, EB .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (25) :2599-2610

[25] Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J].

Pearson, TA ;

Mensah, GA ;

Alexander, RW ;

Anderson, JL ;

Cannon, RO ;

Criqui, M ;

Fadl, YY ;

Fortmann, SP ;

Hong, Y ;

Myers, GL ;

Rifai, N ;

Smith, SC ;

Taubert, K ;

Tracy, RP ;

Vinicor, F .

CIRCULATION, 2003, 107 (03) :499-511

[26] Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men [J].

Pirro, M ;

Bergeron, J ;

Dagenais, GR ;

Bernard, PM ;

Cantin, B ;

Després, JP ;

Lamarche, B .

ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (20) :2474-2480

[27] Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease - Prospective analysis from the Women's Health Initiative observational study [J].

Pradhan, AD ;

Manson, JE ;

Rossouw, JE ;

Siscovick, DS ;

Mouton, CP ;

Rifai, N ;

Wallace, RB ;

Jackson, RD ;

Pettinger, MB ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (08) :980-987

[28] Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein [J].

Ridker, Paul M. ;

Danielson, Eleanor ;

Fonseca, Francisco A. H. ;

Genest, Jacques ;

Gotto, Antonio M., Jr. ;

Kastelein, John J. P. ;

Koenig, Wolfgang ;

Libby, Peter ;

Lorenzatti, Alberto J. ;

MacFadyen, Jean G. ;

Nordestgaard, Borge G. ;

Shepherd, James ;

Willerson, James T. ;

Glynn, Robert J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21) :2195-2207

[29] Development and validation of improved algorithms for the assessment of global cardiovascular risk in women - The Reynolds Risk Score [J].

Ridker, Paul M. ;

Buring, Julie E. ;

Rifai, Nader ;

Cook, Nancy R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (06) :611-619

[30] Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial [J].

Ridker, Paul M. ;

Danielson, Eleanor ;

Fonseca, Francisco A. H. ;

Genest, Jacques ;

Gotto, Antonio M., Jr. ;

Kastelein, John J. P. ;

Koenig, Wolfgang ;

Libby, Peter ;

Lorenzatti, Alberto J. ;

MacFadyen, Jean G. ;

Nordestgaard, Borge G. ;

Shepherd, James ;

Willerson, James T. ;

Glynn, Robert J. .

LANCET, 2009, 373 (9670) :1175-1182

← 1 2 3 4 5 →